7Baggers

Phreesia, Inc
(NYSE:PHR) 

PHR stock logo

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient pay...

Founded: 2005
Full Time Employees: 532
CEO: Chaim Indig  
Sector: Healthcare
Industry: Health Information Services
TechnologySaaS
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 2021-10-31 2021-07-31 2021-04-30 2021-01-31 2020-10-31 2020-07-31 2020-04-30 2020-01-31 2019-10-31 2019-07-31 
                                
      revenue:
    		                            
      subscription and related services
    		52,721,000 55,924,000 55,480,000 53,702,000 54,355,000 51,793,000 49,363,000 48,612,000 46,742,000 45,653,000 42,595,000 39,301,000 37,887,000 35,813,000 32,992,000 31,069,000 29,101,000 26,445,000 24,365,000 22,885,000 21,819,000 18,846,000 17,468,000 17,129,000 15,599,000 15,065,000 14,606,000 14,003,676 
      payment solutions
    		41,941,000                            
      network solutions
    		36,273,000 35,423,000 37,431,000 35,161,000 31,656,000 33,212,000 32,733,000 28,203,000 27,415,000 25,844,000 25,806,000 22,898,000 21,705,000 20,993,000 20,485,000              
      total revenues
    		130,935,000 127,067,000 120,333,000 117,255,000 115,936,000 109,681,000 106,800,000 102,115,000 101,217,000 95,005,000 91,619,000 85,830,000 83,845,000 51,081,000 73,103,000 67,867,000 63,354,000 38,803,250 55,915,000 51,007,000 48,291,000 26,717,250 38,464,000 35,009,000 33,396,000 22,992,000 32,843,000 30,816,168 
      yoy
    		12.94% 15.85% 12.67% 14.83% 14.54% 15.45% 16.57% 18.97% 20.72% 85.99% 25.33% 26.47% 32.34% 31.64% 30.74% 33.05% 31.19% 45.24% 45.37% 45.70% 44.60% 16.20% 17.11% 13.61%     
      qoq
    		3.04% 5.60% 2.63% 1.14% 5.70% 2.70% 4.59% 0.89% 6.54% 3.70% 6.74% 2.37% 64.14% -30.12% 7.72% 7.12% 63.27% -30.60% 9.62% 5.62% 80.75% -30.54% 9.87% 4.83% 45.25% -29.99% 6.58%  
      expenses:
    		                            
      cost of revenue
    		17,659,000 18,992,000 18,338,000 17,398,000 16,637,000 16,507,000 17,854,000 16,143,000 15,723,000 16,140,000 15,529,000 14,449,000 14,907,000 15,123,000 14,562,000 14,873,000 14,386,000 12,459,000 11,644,000 10,032,000 8,534,000 6,984,000 6,472,000 5,271,000 4,734,000 4,237,000 4,388,000 4,210,203 
      payment solutions expense
    		25,675,000                            
      sales and marketing
    		24,209,000 24,656,000 24,148,000 25,396,000 26,043,000 28,863,000 30,071,000 30,184,000 32,011,000 35,873,000 36,478,000 37,244,000 37,413,000 36,260,000 36,631,000 38,341,000 40,031,000 37,206,000 32,036,000 22,167,000 15,012,000 12,959,000 10,481,000 10,098,000 9,434,000 8,187,000 8,348,000 8,120,137 
      research and development
    		28,328,000 30,925,000 29,453,000 29,274,000 31,829,000 29,626,000 29,315,000 29,542,000 28,881,000 29,862,000 28,544,000 27,471,000 26,469,000 25,398,000 22,669,000 22,542,000 20,635,000 17,495,000 15,273,000 11,443,000 8,054,000 6,355,000 5,732,000 5,530,000 5,005,000 4,861,000 4,774,000 4,689,990 
      general and administrative
    		18,361,000 26,965,000 17,488,000 19,042,000 16,408,000 18,415,000 19,633,000 19,497,000 19,052,000 18,821,000 20,240,000 20,988,000 19,877,000 19,856,000 19,600,000 20,073,000 20,855,000 21,738,000 18,021,000 16,244,000 12,671,000 11,739,000 10,370,000 9,631,000 8,720,000 9,609,000 7,184,000 7,420,179 
      depreciation
    		3,371,000 3,508,000 3,199,000 3,279,000 2,986,000 3,172,000 3,566,000 3,921,000 3,524,000 4,353,000 4,483,000 4,244,000 4,504,000 4,625,000 4,865,000 4,220,000 4,278,000 4,268,000 3,719,000 3,701,000 3,297,000 2,645,000 2,447,000 2,410,000 2,268,000 2,309,000 2,153,000 2,136,245 
      amortization
    		6,583,000 6,180,000 4,279,000 4,130,000 3,892,000 3,651,000 3,521,000 3,382,000 3,149,000 3,900,000 2,980,000 2,537,000 2,486,000 2,296,000 1,817,000 1,599,000 1,604,000 1,573,000 1,513,000 1,580,000 1,651,000 1,607,000 1,546,000 1,632,000 1,353,000 1,348,000 1,325,000 1,279,106 
      total expenses
    		124,186,000 132,624,000 116,594,000 118,762,000 119,223,000 117,293,000 120,643,000 119,337,000 120,637,000 124,583,000 123,664,000 122,785,000 121,746,000 116,399,000 112,914,000 114,202,000 113,947,000 104,636,000 91,655,000 74,815,000 58,944,000 50,089,000 44,578,000 41,319,000 38,362,000 37,488,000 35,074,000 34,956,535 
      operating income
    		6,749,000 -5,557,000 3,739,000 -1,507,000 -3,287,000 -7,612,000 -13,843,000 -17,222,000 -19,420,000 -29,578,000 -32,045,000 -36,955,000 -37,901,000 -39,813,000 -39,811,000 -46,335,000 -50,593,000 -46,616,000 -35,740,000 -23,808,000 -10,653,000 -8,281,000 -6,114,000 -6,310,000 -4,966,000 -4,672,000 -2,231,000 -4,140,367 
      yoy
    		-305.32% -27.00% -127.01% -91.25% -83.07% -74.26% -56.80% -53.40% -48.76% -25.71% -19.51% -20.24% -25.09% -14.59% 11.39% 94.62% 374.92% 462.93% 484.56% 277.31% 114.52% 77.25% 174.05% 52.40%     
      qoq
    		-221.45% -248.62% -348.11% -54.15% -56.82% -45.01% -19.62% -11.32% -34.34% -7.70% -13.29% -2.50% -4.80% 0.01% -14.08% -8.42% 8.53% 30.43% 50.12% 123.49% 28.64% 35.44% -3.11% 27.06% 6.29% 109.41% -46.12%  
      operating margin %
    		5.15% -4.37% 3.11% -1.29% -2.84% -6.94% -12.96% -16.87% -19.19% -31.13% -34.98% -43.06% -45.20% -77.94% -54.46% -68.27% -79.86% -120.13% -63.92% -46.68% -22.06% -30.99% -15.90% -18.02% -14.87% -20.32% -6.79% -13.44% 
      other income
    		-7,000 1,273,000 1,006,000 336,000 338,000   -86,000    50,000    38,000 -31,000 60,000 -114,000 -90,000 66,000 230,000 62,000 424,000 -715,000 -283,000 77,000 327,421 
      loss on extinguishment of debt
    		-17,000                            
      interest expense
    		-2,299,000                            
      interest income
    		297,000 1,415,000 380,000 608,000 -230,000 19,000 26,000 46,000 239,000 184,000 523,000 786,000 718,000 1,592,000 61,000 -206,000 -383,000 -328,000 -311,000 -207,000 -238,000 -367,000 -467,000 -419,000 -320,000 -676,000 -219,000 -745,205 
      total other income
    		-2,026,000 -4,766,000 1,386,000 944,000 108,000 2,236,000 -118,000 -40,000 208,000 -851,000 476,000 836,000 676,000       -297,000  -358,750 -405,000 5,000 -1,035,000 -959,000 -142,000 -3,301,635 
      income before income tax expense
    		4,723,000 345,750 5,125,000                          
      income tax expense
    		-1,760,000 -93,000 -854,000                          
      net income
    		2,963,000 1,295,000 4,271,000 654,000 -3,914,000 -6,390,000 -14,403,000 -18,012,000 -19,722,000 -30,646,000 -31,941,000 -36,767,000 -37,531,000 -38,021,000 -40,167,000 -46,716,000 -51,242,000 -46,451,000 -36,343,000 -24,393,000 -10,974,000 -8,096,000 -6,713,000 -6,371,000 -6,112,000 -3,668,000 -2,437,000 -7,493,191 
      yoy
    		-175.70% -120.27% -129.65% -103.63% -80.15% -79.15% -54.91% -51.01% -47.45% -19.40% -20.48% -21.30% -26.76% -18.15% 10.52% 91.51% 366.94% 473.75% 441.38% 282.88% 79.55% 120.72% 175.46% -14.98%     
      qoq
    		128.80% -69.68% 553.06% -116.71% -38.75% -55.63% -20.04% -8.67% -35.65% -4.05% -13.13% -2.04% -1.29% -5.34% -14.02% -8.83% 10.31% 27.81% 48.99% 122.28% 35.55% 20.60% 5.37% 4.24% 66.63% 50.51% -67.48%  
      net income margin %
    		2.26% 1.02% 3.55% 0.56% -3.38% -5.83% -13.49% -17.64% -19.48% -32.26% -34.86% -42.84% -44.76% -74.43% -54.95% -68.83% -80.88% -119.71% -65.00% -47.82% -22.72% -30.30% -17.45% -18.20% -18.30% -15.95% -7.42% -24.32% 
      net income per share
    		    -0.07 -0.11 -0.25 -0.31 -0.35 -0.55 -0.58 -0.68 -0.7 -0.72 -0.76 -0.89 -0.99 -0.93 -0.71 -0.48 -0.24 -0.18 -0.17 -0.17 -0.16 1.35 -0.07 -10.42 
      basic
    		0.05 0.02 0.07 0.01                         
      diluted
    		0.05 0.02 0.07 0.01                         
      weighted-average common shares outstanding:
    		                            
      basic
    		60,944,962 59,737,915 60,008,780 59,591,545                         
      diluted
    		62,040,865 61,494,878 61,559,849 61,685,811                         
      beginning with the fourth quarter of the fiscal year ended january 31, 2026, the revenue line previously labeled “payment processing fees” was relabeled “payment solutions” to reflect the expanded scope of our payments offerings following the accessone acquisition (as defined herein), which closed on november 12, 2025. additionally, “payment processing expense” was relabeled “payment solutions expense.” prior period amounts have not been reclassified, as the company did not own the acquired operations in prior periods and the change in presentation did not affect any previously reported amounts. see note 2 - basis of presentation.
    		                            
      payment processing fees
    		 21,434,750 27,422,000 28,392,000 29,925,000 24,676,000 24,704,000 25,300,000 27,060,000 23,508,000 23,218,000 23,631,000 24,253,000 19,780,000 19,626,000 19,581,000 19,381,000 16,140,000 16,111,000 16,306,000 16,644,000 13,448,000 12,917,000 11,828,000 11,707,000 11,719,000 11,559,000 11,664,507 
      payment processing expense
    		 15,340,000 19,689,000 20,243,000 21,428,000 17,059,000 16,683,000 16,668,000 18,297,000 15,634,000 15,410,000 15,852,000 16,090,000 12,841,000 12,770,000 12,554,000 12,158,000 9,897,000 9,449,000 9,648,000 9,725,000 7,800,000 7,530,000 6,747,000 6,848,000 6,937,000 6,902,000 7,100,675 
      loss before income tax benefit
    		   -563,000                         
      income tax benefit
    		   1,217,000                         
      income before provision for income taxes
    		    -3,179,000 -5,376,000 -13,961,000 -17,262,000 -19,212,000 -30,429,000 -31,569,000 -36,119,000 -37,225,000 -38,192,000 -39,961,000 -46,503,000 -51,007,000 -17,773,750 -36,165,000 -24,105,000 -10,825,000 -4,706,250 -6,519,000 -6,305,000 -6,001,000 -4,110,500 -2,373,000 -7,442,002 
      provision for income taxes
    		    -735,000 -1,014,000 -442,000 -750,000 -510,000 -217,000 -372,000 -648,000 -306,000 171,000 -206,000 -213,000 -235,000 -153,750 -178,000 -288,000 -149,000 -92,750 -194,000 -66,000 -111,000 -45,750 -64,000 -51,189 
      net income per share
    		    -0.07 -0.11 -0.25 -0.31 -0.35 -0.55 -0.58 -0.68 -0.7 -0.72 -0.76 -0.89 -0.99 -0.93 -0.71 -0.48 -0.24 -0.18 -0.17 -0.17 -0.16 1.35 -0.07 -10.42 
      weighted-average common shares outstanding, basic and diluted
    		    58,920,782 57,589,687 57,891,591 57,502,959 56,666,311 54,561,449 55,251,074 53,794,060 53,347,709 52,440,067 52,606,400 52,325,209 51,938,887 49,888,436 51,020,271 50,577,614 45,416,431 39,519,640 38,511,370 37,735,155 37,308,084 20,301,189 35,790,951 6,793,363 
      other expense
    		     -65,250 -144,000  -31,000 -9,750 -47,000  -42,000 -51,000 -211,000              
      total other expense
    		             -183,000 -150,000 -168,000 -414,000 -268,000 -425,000  -172,000        
      life sciences
    		               17,217,000 14,872,000 15,435,000 15,439,000 11,816,000 9,828,000 9,514,000 8,079,000 6,052,000 6,090,000 6,032,000 6,678,000 5,147,985 
      change in fair value of warrant liability
    		                           -2,883,851 
      preferred stock dividend paid
    		                         -3,738,750  -14,955,101 
      accretion of redeemable preferred stock
    		                           -48,311,988 
      net loss attributable to common stockholders, basic and diluted
    		                     -8,096,000 -6,713,000 -6,371,000 -6,112,000 -21,938,750 -2,437,000 -70,760,280 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 2021-10-31 2021-07-31 2021-04-30 2021-01-31 2020-10-31 2020-07-31 2020-04-30 2020-01-31 2019-10-31 2019-07-31 
                                  
        assets
      		                            
        current:
      		                            
        cash, cash equivalents and restricted cash
      		74,706,000                            
        settlement assets
      		32,720,000 32,999,000 25,391,000 28,875,000 33,006,000 29,176,000 25,046,000 25,320,000 30,063,000 28,072,000 24,083,000 25,158,000 26,539,000 22,599,000 20,710,000 19,725,000 21,305,000 19,590,000 16,323,000 15,503,000 16,788,000 15,488,000 12,267,000 10,717,000 8,672,000 12,368,000 10,384,000 11,298,451 
        accounts receivable
      		89,607,000 97,453,000 88,257,000 76,842,000 75,099,000 73,617,000 71,408,000 61,274,000 66,255,000 64,863,000 57,439,000 53,913,000 52,932,000 51,394,000 44,356,000 46,958,000 46,354,000 40,262,000 35,460,000 30,356,000 29,964,000 29,052,000 27,594,000 22,972,000 24,223,000 21,978,000 20,008,000 16,787,723 
        cardholder receivables
      		29,740,000 38,330,000                           
        deferred purchase price receivables
      		23,247,000 18,003,000                           
        accrued interest and fees receivables
      		711,000 840,000                           
        deferred contract acquisition costs
      		401,000 410,000 427,000 431,000 414,000 401,000 362,000 841,000 768,000 768,000 777,000 820,000 908,000 1,056,000 1,218,000 1,363,000 1,520,000 1,642,000 1,705,000 1,817,000 1,895,000 1,693,000 1,708,000 1,684,000 1,788,000 1,720,000 1,631,000 1,631,384 
        prepaid expenses and other current assets
      		16,129,000 17,978,000 20,460,000 18,227,000 16,019,000 15,871,000 11,017,000 11,695,000 14,288,000 14,461,000 13,575,000 11,662,000 10,002,000 10,709,000 11,001,000 7,721,000 10,853,000 11,043,000 10,450,000 6,161,000 7,906,000 7,254,000 6,825,000 8,378,000 5,435,000 5,157,000   
        total current assets
      		267,261,000 279,843,000 240,906,000 222,641,000 215,409,000 203,285,000 189,573,000 180,928,000 190,901,000 195,684,000 199,240,000 219,230,000 240,148,000 262,441,000 286,874,000 316,496,000 349,222,000 386,349,000 464,333,000 493,691,000 507,233,000 272,268,000 302,512,000 127,950,000 130,370,000 131,538,000 128,699,000 135,787,787 
        property and equipment
      		20,568,000 20,332,000 21,111,000 22,769,000 23,492,000 23,651,000 25,973,000 20,955,000 22,112,000 16,902,000 19,899,000 22,816,000 26,228,000 21,670,000 26,327,000 28,558,000 31,807,000 34,645,000 32,755,000 26,868,000 25,068,000 26,660,000 19,160,000 17,070,000 14,986,000 14,487,000 14,364,000 14,564,348 
        capitalized internal-use software, net of accumulated amortization of 73,362 and 69,390 as of april 30, 2026 and january 31, 2026, respectively
      		54,624,000                            
        operating lease right-of-use assets
      		1,769,000 2,002,000 820,000 1,043,000 1,262,000 1,477,000 1,656,000 1,863,000 857,000 266,000 431,000 227,000 336,000 569,000 794,000 1,315,000 2,048,000 2,337,000 2,005,000 2,252,000 2,497,000 2,654,000 3,192,000 2,406,000 2,795,000    
        intangible assets, net of accumulated amortization of 16,099 and 13,489 as of april 30, 2026 and january 31, 2026, respectively
      		77,151,000                            
        goodwill
      		169,513,000 170,064,000 75,845,000 75,845,000 75,845,000 75,845,000 75,845,000 75,845,000 75,845,000 75,845,000 75,468,000 40,611,000 33,736,000 33,736,000 33,836,000 33,836,000 33,621,000 33,621,000 8,211,000 8,211,000 8,211,000 8,307,000 250,000 250,000 250,000 250,000 251,000 250,190 
        deferred tax assets
      		1,593,000 1,593,000                           
        other assets
      		7,283,000 2,442,000 3,081,000 3,856,000 3,123,000 2,668,000 1,870,000 2,251,000 2,575,000 2,879,000 1,668,000 1,989,000 2,632,000 3,255,000 4,016,000 4,112,000 4,669,000 4,157,000 2,795,000 2,543,000 1,401,000 1,670,000 207,000 108,000 128,000 180,000 1,324,000 1,306,044 
        long-term cardholder receivables
      		59,494,000 47,723,000                           
        long-term deferred purchase price receivables
      		6,654,000 5,422,000                           
        total assets
      		666,141,000 663,790,000 423,472,000 408,629,000 400,395,000 388,415,000 375,703,000 362,235,000 372,086,000 370,326,000 374,647,000 340,442,000 353,852,000 370,057,000 397,294,000 425,988,000 459,092,000 494,476,000 529,127,000 551,226,000 561,203,000 326,666,000 338,050,000 160,287,000 161,300,000 158,758,000 155,909,000 162,987,508 
        liabilities and stockholders’ equity
      		                            
        settlement obligations
      		32,720,000 32,999,000 25,391,000 28,875,000 33,006,000 29,176,000 25,046,000 25,320,000 30,063,000 28,072,000 24,083,000 25,158,000 26,539,000 22,599,000 20,710,000 19,725,000 21,305,000 19,590,000 16,323,000 15,503,000 16,788,000 15,488,000 12,267,000 10,717,000 8,672,000 12,368,000 10,384,000 11,298,451 
        current portion of debt and finance lease liabilities
      		5,301,000 7,971,000                   4,103,000  4,722,000 4,939,000     
        current portion of operating lease liabilities
      		1,062,000 1,254,000 746,000 941,000 957,000 964,000 1,021,000 989,000 558,000 393,000 571,000 416,000 692,000 934,000 1,143,000 1,298,000 1,304,000 1,281,000 1,116,000 1,133,000 1,153,000 1,087,000 1,288,000 1,221,000 1,414,000    
        accounts payable
      		11,891,000 11,477,000 6,218,000 6,527,000 3,204,000 5,622,000 15,870,000 6,976,000 6,684,000 8,480,000 10,904,000 7,948,000 7,602,000 10,836,000 11,108,000 10,088,000 5,872,000 5,119,000 11,602,000 5,483,000 313,000 4,389,000 4,215,000 5,103,000 7,649,000 6,017,000 5,949,000 10,979,101 
        accrued expenses
      		30,521,000 41,257,000 30,517,000 34,783,000 34,059,000 37,460,000 29,080,000 32,668,000 33,227,000 37,130,000 28,290,000 27,794,000 23,284,000 21,810,000 20,344,000 17,925,000 18,416,000 20,128,000 18,885,000 18,101,000 15,116,000 18,324,000 12,662,000 9,838,000 11,374,000 9,243,000 8,018,000 8,250,017 
        due to healthcare providers
      		30,331,000 38,056,000                           
        deferred revenue
      		39,561,000 49,522,000 29,712,000 26,913,000 31,146,000 32,758,000 22,188,000 21,370,000 24,075,000 24,113,000 22,034,000 16,441,000 17,881,000 17,688,000 13,933,000 17,195,000 17,782,000 16,493,000 12,434,000 12,938,000 13,223,000 10,838,000 6,623,000 6,257,000 6,629,000 5,401,000 5,326,000 5,782,499 
        other current liabilities
      		722,000 705,000     7,130,000 7,515,000 5,930,000 5,875,000 5,790,000                  
        total current liabilities
      		152,109,000 183,241,000 98,783,000 105,135,000 110,720,000 114,023,000 109,201,000 101,999,000 108,282,000 110,119,000 98,425,000 84,869,000 82,980,000 79,039,000 72,721,000 71,948,000 70,779,000 68,432,000 64,957,000 57,652,000 50,696,000 54,990,000 41,777,000 38,075,000 38,104,000 35,353,000 32,090,000 38,627,597 
        long-term debt and finance lease liabilities
      		85,303,000 92,117,000                   5,532,000 6,471,000 24,439,000 23,131,000     
        operating lease liabilities, non-current
      		891,000 1,107,000 132,000 179,000 401,000 646,000 840,000 1,075,000 512,000 134,000 174,000 216,000 257,000 349,000 461,000 633,000 947,000 1,276,000 1,117,000 1,412,000 1,701,000 1,899,000       
        long-term due to healthcare providers
      		60,826,000 45,329,000                           
        long-term deferred revenue
      		3,223,000 244,000 151,000 81,000 112,000 119,000 199,000 63,000 79,000 97,000 97,000 99,000 179,000 125,000 1,000 10,000 148,000 65,000           
        long-term deferred tax liabilities
      		4,624,000 4,498,000 683,000 626,000 568,000 484,000 446,000 390,000 333,000 270,000 222,000 183,000 136,000                
        other long-term liabilities
      		75,000 47,000 41,000 45,000 246,000 185,000 133,000 76,000 1,448,000 2,857,000 4,286,000                  
        total liabilities
      		307,051,000 326,583,000 103,143,000 110,642,000 118,209,000 123,607,000 121,111,000 110,900,000 119,344,000 118,877,000 110,049,000 93,422,000 90,241,000 82,238,000 76,949,000 77,524,000 77,873,000 77,196,000 71,208,000 64,662,000 57,929,000 63,360,000 68,374,000 62,600,000 61,386,000 56,893,000 53,416,000 60,134,707 
        commitments and contingencies
      		                            
        stockholders’ equity:
      		                            
        preferred stock, undesignated, 0.01 par value—20,000,000 shares authorized as of both april 30, 2026 and january 31, 2026; no shares issued or outstanding as of both april 30, 2026 and january 31, 2026
      		                            
        common stock
      		632,000 620,000 616,000 611,000 608,000 601,000 594,000 591,000 587,000 577,000 570,000 554,000 548,000 542,000 534,000 531,000 527,000 521,000 513,000 509,000 503,000 449,000 440,000 379,000 376,000 366,000 359,000 357,594 
        additional paid-in capital
      		1,201,871,000 1,181,679,000 1,166,078,000 1,147,540,000 1,132,124,000 1,111,274,000 1,094,629,000 1,076,969,000 1,060,365,000 1,039,361,000 1,021,870,000 971,120,000 947,353,000 926,957,000 911,526,000 896,264,000 880,567,000 860,657,000 849,450,000 840,287,000 831,632,000 579,599,000 573,786,000 395,145,000 390,981,000 386,383,000 382,951,000 380,875,148 
        accumulated deficit
      		-796,227,000 -799,190,000 -800,485,000 -804,756,000 -805,410,000 -801,496,000 -795,106,000 -780,703,000 -762,691,000 -742,969,000 -712,323,000 -680,382,000 -643,615,000 -606,084,000 -568,063,000 -527,896,000 -481,180,000 -429,938,000 -383,487,000 -347,144,000 -322,751,000 -311,777,000 -303,681,000 -296,968,000 -290,597,000 -284,485,000 -280,817,000 -278,379,941 
        accumulated other comprehensive loss
      		-571,000 -382,000    -51,000 -5,000 -2,000                     
        treasury stock
      		-46,615,000 -45,520,000 -45,520,000 -45,520,000 -45,520,000 -45,520,000 -45,520,000 -45,520,000 -45,520,000 -45,520,000 -45,519,000 -44,272,000 -40,675,000 -33,596,000 -23,652,000 -20,435,000 -18,695,000 -13,960,000 -8,557,000 -7,088,000 -6,110,000 -4,965,000 -869,000 -869,000 -846,000 -399,000   
        total stockholders’ equity
      		359,090,000 337,207,000 320,329,000 297,987,000 282,186,000 264,808,000 254,592,000 251,335,000 252,742,000 251,449,000 264,598,000 247,020,000 263,611,000 287,819,000 320,345,000 348,464,000 381,219,000 417,280,000 457,919,000 486,564,000 503,274,000 263,306,000 269,676,000 97,687,000 99,914,000 101,865,000 102,493,000 102,852,801 
        total liabilities and stockholders’ equity
      		666,141,000 663,790,000 423,472,000 408,629,000 400,395,000 388,415,000 375,703,000 362,235,000 372,086,000 370,326,000 374,647,000 340,442,000 353,852,000 370,057,000 397,294,000 425,988,000 459,092,000 494,476,000 529,127,000 551,226,000 561,203,000 326,666,000 338,050,000 160,287,000 161,300,000    
        cash, cash equivalents, and restricted cash
      		 73,830,000                           
        capitalized internal-use software, net of accumulated amortization of 69,390 and 55,991 as of january 31, 2026 and 2025, respectively
      		 54,270,000                           
        intangible assets, net of accumulated amortization of 13,489 and 8,407 as of january 31, 2026 and 2025, respectively
      		 79,761,000                           
        preferred stock, undesignated, 0.01 par value—20,000,000 shares authorized as of both january 31, 2026 and 2025; no shares issued or outstanding as of january 31, 2026 and 2025, respectively
      		                            
        cash and cash equivalents
      		  106,371,000 98,266,000 90,871,000 84,220,000 81,740,000 81,798,000 79,527,000 87,520,000 103,366,000 127,677,000 149,767,000 176,683,000 209,589,000 240,729,000 269,190,000 313,812,000 400,395,000 439,854,000 450,680,000 218,781,000 254,118,000 84,199,000 90,252,000 90,315,000 91,389,000 100,051,186 
        capitalized internal-use software, net of accumulated amortization of 65,681 and 55,991 as of october 31, 2025 and january 31, 2025, respectively
      		  54,093,000                          
        intangible assets, net of accumulated amortization of 11,018 and 8,407 as of october 31, 2025 and january 31, 2025, respectively
      		  25,532,000                          
        deferred tax asset
      		  1,640,000 1,640,000          81,000  75,000 291,000 515,000 150,000 379,000 533,000  496,000 666,000     
        current portion of finance lease liabilities and other debt
      		  6,199,000 7,096,000 8,348,000 8,043,000 8,866,000 7,161,000 7,745,000 6,056,000 6,753,000 7,112,000 6,982,000 5,172,000 5,483,000 5,717,000 6,100,000 5,821,000 4,597,000 4,494,000         
        long-term finance lease liabilities and other debt
      		  3,353,000 4,576,000 6,162,000 8,150,000 10,292,000 7,297,000 8,690,000 5,400,000 6,845,000 8,055,000 6,689,000 2,725,000 3,766,000 4,933,000 5,999,000 7,423,000 5,134,000 5,598,000         
        preferred stock, undesignated, 0.01 par value—20,000,000 shares authorized as of both october 31, 2025 and january 31, 2025; no shares issued or outstanding as of both october 31, 2025 and january 31, 2025
      		                            
        accumulated other comprehensive income
      		  -360,000 112,000 384,000    1,000                    
        capitalized internal-use software, net of accumulated amortization of 62,272 and 55,991 as of july 31, 2025 and january 31, 2025, respectively
      		   53,881,000                         
        intangible assets, net of accumulated amortization of 10,147 and 8,407 as of july 31, 2025 and january 31, 2025, respectively
      		   26,403,000                         
        preferred stock, undesignated, 0.01 par value—20,000,000 shares authorized as of both july 31, 2025 and january 31, 2025; no shares issued or outstanding as of both july 31, 2025 and january 31, 2025
      		                            
        capitalized internal-use software, net of accumulated amortization of 59,013 and 55,991 as of april 30, 2025 and january 31, 2025, respectively
      		    53,531,000                        
        intangible assets, net of accumulated amortization of 9,277 and 8,407 as of april 30, 2025 and january 31, 2025, respectively
      		    27,273,000                        
        preferred stock, undesignated, 0.01 par value—20,000,000 shares authorized as of both april 30, 2025 and january 31, 2025; no shares issued or outstanding as of both april 30, 2025 and january 31, 2025
      		                            
        capitalized internal-use software, net of accumulated amortization of 55,991 and 45,769 as of january 31, 2025 and 2024, respectively
      		     52,763,000                       
        intangible assets, net of accumulated amortization of 8,407 and 4,925 as of january 31, 2025 and 2024, respectively
      		     28,143,000                       
        preferred stock, undesignated, 0.01 par value—20,000,000 shares authorized as of both january 31, 2025 and 2024; no shares issued or outstanding as of january 31, 2025 and 2024, respectively
      		                            
        capitalized internal-use software, net of accumulated amortization of 53,210 and 45,769 as of october 31, 2024 and january 31, 2024, respectively
      		      51,322,000                      
        intangible assets, net of accumulated amortization of 7,536 and 4,925 as of october 31, 2024 and january 31, 2024, respectively
      		      29,014,000                      
        preferred stock, undesignated, 0.01 par value - 20,000,000 shares authorized as of both october 31, 2024 and january 31, 2024; no shares issued or outstanding as of both october 31, 2024 and january 31, 2024
      		                            
        capitalized internal-use software, net of accumulated amortization of 50,559 and 45,769 as of july 31, 2024 and january 31, 2024, respectively
      		       49,767,000                     
        intangible assets, net of accumulated amortization of 6,666 and 4,925 as of july 31, 2024 and january 31, 2024, respectively
      		       29,884,000                     
        preferred stock, undesignated, 0.01 par value—20,000,000 shares authorized as of both july 31, 2024 and january 31, 2024; no shares issued or outstanding as of both july 31, 2024 and january 31, 2024
      		                            
        capitalized internal-use software, net of accumulated amortization of 48,048 and 45,769 as of april 30, 2024 and january 31, 2024, respectively
      		        48,248,000                    
        intangible assets, net of accumulated amortization of 5,796 and 4,925 as of april 30, 2024 and january 31, 2024, respectively
      		        30,754,000                    
        preferred stock, undesignated, 0.01 par value—20,000,000 shares authorized as of both april 30, 2024 and january 31, 2024; no shares issued or outstanding as of both april 30, 2024 and january 31, 2024
      		                            
        capitalized internal-use software, net of accumulated amortization of 45,769 and 37,236 as of january 31, 2024 and 2023, respectively
      		         46,139,000                   
        intangible assets, net of accumulated amortization of 4,925 and 2,549 as of january 31, 2024 and 2023, respectively
      		         31,625,000                   
        preferred stock, undesignated, 0.01 par value—20,000,000 shares authorized as of both january 31, 2024 and 2023; no shares issued or outstanding as of january 31, 2024 and 2023, respectively
      		                            
        capitalized internal-use software, net of accumulated amortization of 43,744 and 37,236 as of october 31, 2023 and january 31, 2023, respectively
      		          44,257,000                  
        intangible assets, net of accumulated amortization of 4,044 and 2,549 as of october 31, 2023 and january 31, 2023, respectively
      		          32,506,000                  
        capitalized internal-use software, net of accumulated amortization of 41,552 and 37,236 as of july 31, 2023 and january 31, 2023, respectively
      		           41,205,000                 
        intangible assets, net of accumulated amortization of 3,256 and 2,549 as of july 31, 2023 and january 31, 2023, respectively
      		           12,994,000                 
        capitalized internal-use software, net of accumulated amortization of 39,380 and 37,236 as of april 30, 2023 and january 31, 2023, respectively
      		            38,152,000                
        intangible assets, net of accumulated amortization of 2,892 and 2,549 as of april 30, 2023 and january 31, 2023, respectively
      		            11,058,000                
        capitalized internal-use software, net of accumulated amortization of 37,236 and 31,139 as of january 31, 2023 and 2022, respectively
      		             35,150,000               
        intangible assets, net of accumulated amortization of 2,549 and 1,178 as of january 31, 2023 and 2022, respectively
      		             11,401,000               
        capitalized internal-use software, net of accumulated amortization of 35,283 and 31,139 as of october 31, 2022 and january 31, 2022, respectively
      		              31,804,000              
        intangible assets, net of accumulated amortization of 2,206 and 1,178 as of october 31, 2022 and january 31, 2022, respectively
      		              11,744,000              
        capitalized internal-use software, net of accumulated amortization of 33,809 and 31,139 as of july 31, 2022 and january 31, 2022, respectively
      		               27,522,000             
        intangible assets, net of accumulated amortization of 1,864 and 1,178 as of july 31, 2022 and january 31, 2022, respectively
      		               12,086,000             
        capitalized internal-use software, net of accumulated amortization of 32,400 and 31,139 as of april 30, 2022 and january 31, 2022, respectively
      		                22,807,000            
        intangible assets, net of accumulated amortization of 1,521 and 1,178 as of april 30, 2022 and january 31, 2022, respectively
      		                12,429,000            
        capitalized internal-use software, net of accumulated amortization of 31,139 and 25,476 as of january 31, 2022 and 2021, respectively
      		                 17,643,000           
        intangible assets, net of accumulated amortization of 1,178 and 525 as of january 31, 2022 and 2021, respectively
      		                 12,772,000           
        capitalized internal-use software, net of accumulated amortization of 29,838 and 25,476 as of october 31, 2021 and january 31, 2021, respectively
      		                  14,079,000          
        intangible assets, net of accumulated amortization of 907 and 525 as of october 31, 2021 and january 31, 2021, respectively
      		                  2,343,000          
        capitalized internal-use software, net of accumulated amortization of 28,451 and 25,476 as of july 31, 2021 and january 31, 2021, respectively
      		                   12,299,000         
        intangible assets, net of accumulated amortization of 780 and 525 as of july 31, 2021 and january 31, 2021, respectively
      		                   2,470,000         
        capitalized internal-use software, net of accumulated amortization of 26,998 and 25,476 as of april 30, 2021 and january 31, 2021, respectively
      		                    11,225,000        
        intangible assets, net of accumulated amortization of 653 and 525 as of april 30, 2021 and january 31, 2021, respectively
      		                    2,597,000        
        capitalized internal-use software, net of accumulated amortization of 25,476 and 19,554
      		                     10,476,000       
        intangible assets, net of accumulated amortization of 525 and 271
      		                     2,725,000       
        long-term deferred tax assets
      		                     658,000    775,000   
        short-term debt and finance lease liabilities
      		                     4,864,000       
        figures as of january 31, 2021 reflect the company's february 1, 2020 adoption of accounting standards codification no. 842, leases (asc 842). for additional details, see note 3(ac), "summary of significant accounting policies — impact of recently adopted accounting pronouncements."
      		                            
        capitalized internal-use software, net of accumulated amortization of 23,907 and 19,554
      		                      9,986,000      
        intangible assets, net of accumulated amortization of 450 and 271
      		                      1,020,000      
        operating lease liabilities, noncurrent
      		                      2,158,000 1,394,000 1,578,000    
        figures as of october 31, 2020 reflect the company's february 1, 2020 adoption of accounting standards codification no. 842, leases (asc 842). for additional details, see note 3(c), "summary of significant accounting policies — impact of recently adopted accounting pronouncements."
      		                            
        capitalized internal-use software, net of accumulated amortization of 22,420 and 19,554
      		                       9,501,000     
        intangible assets, net of accumulated amortization of 390 and 271
      		                       1,080,000     
        figures as of july 31, 2020 reflect the company's february 1, 2020 adoption of accounting standards update ("asu") no. 2016-02, leases. for additional details, see note 3(c), "summary of significant accounting policies — impact of recently adopted accounting pronouncements."
      		                            
        capitalized internal-use software, net of accumulated amortization of 20,847 and 19,554
      		                        9,198,000    
        intangible assets, net of accumulated amortization of 331 and 271
      		                        1,139,000    
        long-term deferred tax asset
      		                        719,000    
        current portion of finance lease liabilities
      		                        2,366,000    
        long-term debt
      		                        19,470,000 19,444,000 19,355,000 19,208,348 
        finance lease liabilities, noncurrent
      		                        2,234,000    
        figures as of april 30, 2020 reflect the company's february 1, 2020 adoption of accounting standards update ("asu") no. 2016-02, leases. for additional details, see note 3(c), "summary of significant accounting policies — impact of recently adopted accounting pronouncements."
      		                            
        capitalized internal-use software, net of accumulated amortization of 19,554 and 14,621
      		                         8,735,000   
        intangibles assets, net of accumulated amortization of 271 and 33
      		                         1,199,000   
        liabilities, redeemable preferred stock and stockholders’ equity
      		                            
        current portion of long-term debt
      		                            
        current portion of capital leases
      		                         2,324,000 2,413,000 2,317,529 
        capital leases, net of current portion
      		                         2,096,000 1,971,000 2,298,762 
        warrant liability
      		                            
        redeemable preferred stock:
      		                            
        senior a redeemable convertible preferred stock, 0.01 par value— 14,500,000 shares authorized as of january 31, 2019; 13,674,365 shares issued and outstanding as of january 31, 2019;
      		                            
        senior b redeemable convertible preferred stock, 0.01 par value—10,820,169 shares authorized as of january 31, 2019; 9,197,142 shares issued and outstanding as of january 31, 2019;
      		                            
        junior convertible preferred stock, 0.01 par value— 34,000,000 shares authorized as of january 31, 2019; 32,746,041 shares issued and outstanding as of january 31, 2019;
      		                            
        redeemable preferred stock, 0.01 par value— 44,000,000 shares authorized as january 31, 2019; 42,560,530 shares issued and outstanding as of january 31, 2019;
      		                            
        total redeemable preferred stock
      		                            
        stockholders’ equity
      		                            
        total liabilities, redeemable preferred stock and stockholders’ equity
      		                         158,758,000 155,909,000 162,987,508 
        prepaid expenses
      		                          5,287,000 6,019,043 
        capitalized internal-use software, net of accumulated amortization of 18,266 and 14,621
      		                          8,501,000  
        intangible assets, net of accumulated amortization of 212 and 33
      		                          1,258,000  
        senior a redeemable preferred stock, 0.01 par value - 0 and 14,500,000 shares authorized as of october 31, 2019 and january 31, 2019, respectively; 0 and 13,674,365 issued and outstanding as of october 31, 2019 and january 31, 2019, respectively
      		                            
        series b redeemable convertible preferred stock, 0.01 par value - 0 and 10,820,169 shares authorized as of october 31, 2019 and january 31, 2019, respectively; 0 and 9,197,142 shares issued and outstanding as of october 31, 2019 and january 31, 2019, respectively
      		                            
        junior convertible preferred stock, 0.01 par value - 0 and 34,000,000 shares authorized as of october 31, 2019 and january 31, 2019, respectively; 0 and 32,746,041 shares issued and outstanding as of october 31, 2019 and january 31, 2019, respectively
      		                            
        redeemable preferred stock, 0.01 par value - 0 and 44,000,000 shares authorized as of october 31, 2019 and january 31, 2019, respectively; 0 and 42,560,530 shares issued and outstanding as of october 31, 2019 and january 31, 2019, respectively
      		                            
        capitalized internal-use software, net of accumulated amortization of 17,000,579 and 14,621,135
      		                           8,314,329 
        intangible assets, net of accumulated amortization of 152,269 and 33,269
      		                           1,317,731 
        liabilities, redeemable preferred stock and stockholder’s equity
      		                            
        senior a redeemable preferred stock, 0.01 par value - 0 and 14,500,000 shares authorized as of july 31, 2019 and january 31, 2019, respectively; 0 and 13,674,365 issued and outstanding as of july 31, 2019 and january 31, 2019, respectively
      		                            
        series b redeemable convertible preferred stock, 0.01 par value - 0 and 10,820,169 shares authorized as of july 31, 2019 and january 31, 2019, respectively; 0 and 9,197,142 shares issued and outstanding as of july 31, 2019 and january 31, 2019 , respectively
      		                            
        junior convertible preferred stock, 0.01 par value - 0 and 34,000,000 shares authorized as of july 31, 2019 and january 31, 2019, respectively; 0 and 32,746,041 shares issued and outstanding as of july 31, 2019 and january 31, 2019, respectively
      		                            
        redeemable preferred stock, 0.01 par value - 0 and 44,000,000 shares authorized as of july 31, 2019 and january 31, 2019, respectively; 0 and 42,560,530 shares issued and outstanding as of july 31, 2019 and january 31, 2019, respectively
      		                            
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 2021-10-31 2021-07-31 2021-04-30 2021-01-31 2020-10-31 2020-07-31 2020-04-30 2020-01-31 2019-10-31 
                                   
          operating activities:
        		                           
          net income
        		2,963,000 -1,965,000 3,617,000                         
          adjustments to reconcile net income to net cash from operating activities:
        		                           
          depreciation and amortization
        		9,954,000 23,975,000 69,000 531,000 6,878,000 20,799,000 -216,000 630,000 6,673,000 8,253,000 7,463,000 6,781,000 6,990,000 6,921,000 6,682,000 5,819,000 5,882,000 5,841,000 5,232,000 5,281,000 4,948,000 4,252,000 3,993,000 4,042,000 3,621,000 3,657,000 3,477,549 
          stock-based compensation expense
        		13,554,000 51,493,000 -271,000 -995,000 17,225,000 50,450,000 77,000 -392,000 16,840,000 17,864,000 17,963,000 18,648,000 17,138,000  14,782,000 14,558,000 14,151,000  12,929,000 7,273,000 5,774,000  3,316,000 3,428,000 2,872,000 2,345,000 1,765,379 
          amortization of deferred financing costs
        		434,000                           
          loss on extinguishment of debt
        		17,000                         0 187 
          cost of phreesia hardware purchased by customers
        		188,000 787,000 78,000 -279,000 436,000 1,302,000 237,000 -9,000 343,000 387,000 582,000 234,000 416,000 659,000 393,000 269,000 277,000 223,000 176,000 138,000 135,000    172,000 229,000 193,334 
          deferred contract acquisition costs amortization
        		116,000 459,000 -131,000 132,000 110,000 493,000 1,130,000 0 192,000 201,000 235,000 280,000 340,000 378,000 413,000 438,000 467,000 502,000 557,000    505,000 1,250,000 525,000   
          non-cash operating lease expense
        		233,000 690,000 6,000 3,000 215,000 540,000 19,000 15,000 173,000 218,000 142,000 109,000 233,000 225,000 521,000 733,000 289,000 274,000 247,000 227,000 256,000 538,000 451,000 388,000 389,000   
          deferred taxes
        		677,000 -13,328,000 1,640,000 -1,668,000 85,000 157,000 1,000 -7,000 63,000 47,000 39,000 -75,000 217,000               
          changes in operating assets and liabilities:
        		                           
          accounts receivable
        		7,731,000 -11,942,000 -9,635,000 -330,000 -1,490,000 1,329,000 -15,117,000 6,369,000 -1,393,000 -7,844,000 -991,000 -832,000 -1,538,000 -7,038,000 2,602,000 -604,000 -6,092,000 -3,808,000 -5,104,000 -392,000 -912,000 -1,003,000 -4,622,000 1,251,000 -2,245,000 -2,006,000 -3,220,312 
          cash received for sale of receivables
        		7,711,000                           
          accrued interest receivable
        		129,000                           
          prepaid expenses and other assets
        		828,000 559,000 708,000 -2,404,000 -256,000 -2,432,000 -1,862,000 2,453,000 414,000 -1,448,000 -1,530,000 -383,000 1,152,000 1,052,000 -3,992,000 3,640,000 -450,000 -1,506,000 -4,649,000 -228,000 -809,000 340,000 952,000 -4,506,000 1,614,000 2,631,000 713,994 
          accounts payable
        		159,000 3,958,000 -765,000 3,807,000 -1,739,000 -10,182,000 5,762,000 4,122,000 -2,936,000 -767,000 1,189,000 568,000 -2,983,000 363,000 696,000 3,592,000 123,000 -6,609,000 8,540,000 2,018,000 -1,068,000 -1,521,000 -1,025,000 -277,000 -998,000 -1,659,000 -2,919,149 
          accrued expenses and other liabilities
        		-6,985,000 6,346,000 -2,163,000 -398,000 -891,000 3,837,000 -2,263,000 -237,000 -1,155,000 7,665,000 469,000 4,239,000 1,822,000 789,000 948,000 -718,000 1,701,000 2,580,000 -5,288,000 3,403,000 -3,678,000 2,022,000 2,866,000 -755,000 1,871,000   
          payment of due to provider for receivables sold to securitization
        		-5,060,000                           
          lease liabilities
        		-410,000 -865,000 -4,000 14,000 -252,000 -622,000 -1,000 18,000 -219,000 -272,000 -232,000 -405,000 -247,000               
          deferred revenue
        		-8,317,000 5,460,000 7,133,000 -2,645,000 -1,619,000 7,713,000 3,676,000 -2,667,000 -55,000 2,078,000 218,000 -1,812,000 247,000 3,879,000 -3,271,000 -725,000 1,372,000 1,752,000 -504,000 -285,000 2,385,000 4,160,000 366,000 -372,000 1,228,000 75,000 -456,589 
          net cash from operating activities
        		23,922,000 63,347,000 632,000 -15,000 14,850,000 26,596,000 -5,276,000 11,782,000 -721,000 -3,078,000 -6,310,000 -9,331,000 -13,659,000 -15,899,000 -20,748,000 -19,843,000 -33,633,000 -37,979,000 -24,529,000 -6,729,000 -5,473,000 4,077,000 -667,000 -2,423,000 1,903,000 1,274,000 -3,032,715 
          capital expenditures
        		-5,246,000 -17,731,000 -1,464,000 2,190,000 -7,392,000 -19,907,000 3,221,000 -1,957,000 -5,446,000 -7,864,000 -5,311,000 -5,843,000 -6,079,000 -6,599,000 -6,728,000 -5,852,000 -7,024,000 -4,423,000 -14,505,000 -3,154,000 -6,899,000 -2,671,000 -3,384,000 -4,319,000 -3,077,000 -976,000 -3,675,387 
          free cash flows
        		18,676,000 45,616,000 -832,000 2,175,000 7,458,000 6,689,000 -2,055,000 9,825,000 -6,167,000 -10,942,000 -11,621,000 -15,174,000 -19,738,000 -22,498,000 -27,476,000 -25,695,000 -40,657,000 -42,402,000 -39,034,000 -9,883,000 -12,372,000 1,406,000 -4,051,000 -6,742,000 -1,174,000 298,000 -6,708,102 
          investing activities:
        		                           
          collections of cardholder receivables held for investment and deferred purchase price
        		12,352,000                           
          capitalized internal-use software
        		-3,240,000 -9,901,000 40,000 453,000 -3,888,000 -11,814,000 -590,000 1,594,000 -4,570,000 -5,402,000 -4,069,000 -5,088,000 -4,732,000 -5,895,000 -5,334,000 -5,003,000 -5,239,000 -4,423,000 -2,939,000 -2,107,000 -2,916,000 -2,671,000 -1,926,000 -1,577,000 -1,160,000 -976,000 -1,451,286 
          purchases of property and equipment
        		-4,310,000 -7,830,000 -1,504,000 1,737,000 -3,504,000 -8,093,000 3,811,000 -3,551,000 -876,000 -2,462,000 -1,242,000 -755,000 -1,347,000 -704,000 -1,394,000 -849,000 -1,785,000           
          net cash from investing activities
        		4,802,000 -155,213,000 -1,464,000 2,190,000 -7,392,000 -19,907,000 3,221,000 -1,957,000 -5,446,000 -8,158,000 -15,717,000 -9,716,000 -6,079,000 -6,599,000 -6,728,000 -5,852,000 -7,024,000 -40,670,000 -14,505,000 -3,154,000 -6,899,000 -13,982,000 -3,707,000 -4,319,000 -3,077,000 -3,165,000 -3,522,808 
          financing activities:
        		                           
          proceeds from issuance of common stock upon exercise of stock options
        		131,000 616,000 724,000 -14,000 128,000 995,000 -202,000 -128,000 347,000 30,000 250,000 426,000 249,000 378,000 84,000 432,000 709,000 827,000 1,384,000 1,322,000 1,356,000 1,034,000 876,000 739,000 1,736,000 1,364,000 366,798 
          treasury stock to satisfy tax withholdings on stock compensation awards
        		-1,095,000         0 -1,451,000 -3,775,000 -6,950,000 -9,860,000 -3,214,000 -2,002,000 -4,307,000 -5,449,000 -1,586,000 -815,000 -1,145,000       
          proceeds from employee stock purchase plan
        		522,000 1,739,000 57,000 -193,000 768,000 2,078,000 150,000 -223,000 913,000 427,000 919,000 896,000 967,000 489,000 883,000 735,000 1,214,000 832,000 852,000         
          finance lease payments
        		-1,680,000 -5,042,000 727,000 -1,134,000 -1,376,000 -5,916,000 100,000 -715,000 -1,280,000 -1,623,000 -1,729,000 -1,983,000 -1,444,000 -1,415,000 -1,417,000 -1,431,000 -1,468,000 -1,092,000 -1,075,000 -1,050,000 -1,050,000    -525,000   
          principal payments on financing agreements
        		-355,000 -994,000 -8,000 -8,000 -320,000 -895,000 -9,000 -6,000 -289,000 -282,000 -273,000   0 0   -166,000 0         
          debt issuance costs and loan facility fee payments
        		-2,259,000 -3,172,000   -38,000    -152,000 -1,071,000 0    0 -284,000 -113,000           
          financing payments of acquisition-related liabilities
        		     -5,945,000   -1,364,000                   
          debt extinguishment costs
        		-42,000                         0 0 
          proceeds from debt instruments
        		92,240,000                           
          principal payments on debt instruments
        		-98,000,000                           
          payments due to provider for unfunded receivables
        		-15,555,000                           
          net cash from financing activities
        		-26,093,000 73,518,000 1,482,000 -1,311,000 -838,000 -9,835,000 -270,000 444,000 -1,825,000 -4,610,000 -2,284,000 -3,043,000 -7,178,000 -10,408,000 -3,664,000 -2,766,000 -3,965,000 -7,934,000 -425,000 -943,000 244,271,000 -25,432,000 174,293,000 689,000 1,111,000 817,000 -2,107,149 
          effect of exchange rate changes on cash, cash equivalents and restricted cash
        		-64,000                           
          net increase in cash, cash equivalents and restricted cash
        		2,567,000                           
          cash, cash equivalents and restricted cash – beginning of period
        		73,830,000                           
          cash, cash equivalents and restricted cash – end of period
        		76,397,000                           
          supplemental information of non-cash investing and financing information:
        		                           
          non-cash activity related to credit card receivables and deferred purchase price
        		27,717,000                           
          exchange of right of use asset for property and equipment
        		57,000                           
          purchase of property and equipment and capitalized software included in accounts payable and accrued liabilities
        		2,304,000                           
          capitalized stock-based compensation
        		342,000                           
          issuance of stock to settle liabilities for stock-based compensation
        		8,053,000                           
          cash paid for:
        		                           
          interest
        		3,848,000                      214,000   476,000 486,874 
          income taxes
        		1,181,000                           
          reconciliation of cash, cash equivalents and restricted cash shown in statements of cash flows
        		                           
          cash, cash equivalents and restricted cash per balance sheets
        		74,706,000                           
          restricted cash included in other long-term assets
        		1,691,000                           
          total cash, cash equivalents and restricted cash shown in statements of cash flows
        		76,397,000                           
          amortization of deferred financing costs and debt discount
        		 2,916,000 -1,000 0 62,000 174,000 11,000 -10,000 61,000 68,000 84,000 84,000 85,000 83,000 83,000 67,000 77,000 72,000 72,000         
          non-cash gain on settlement
        		                           
          gains and losses for fair value option
        		                           
          collections of principal on receivables originally held for sale to securitization
        		                           
          deferred contract acquisition costs
        		     -493,000 -339,000       -71,000 -179,000 -71,000 -106,000 -420,000 -388,000 -574,000 -1,967,000 249,000 -500,000 -687,000 -714,000 -683,000 -1,529,644 
          payment of due to provider for receivables originally held for sale to securitization
        		                           
          acquisitions, net of cash acquired
        		         -294,000 -10,406,000                 
          constructive financing
        		         0 0                 
          net decrease in cash, cash equivalents and restricted cash
        		                           
          cash and cash equivalents—beginning of year
        		                           
          cash, cash equivalents and restricted cash—end of year
        		                           
          supplemental information of non-cash investing and financing activities:
        		                           
          right of use assets acquired in exchange for operating lease liabilities
        		                           
          property and equipment acquisitions through finance leases
        		                      2,393,000     
          deferred consideration liabilities payable in business combinations
        		                           
          issuance of stock as consideration in business combinations
        		                           
          capitalized software acquired through vendor financing
        		                      0     
          effect of exchange rate changes on cash and cash equivalents
        		  60,000 -120,000 31,000 -96,000 -4,000 -5,000 -1,000                   
          net increase in cash and cash equivalents
        		  710,000 744,000 6,651,000         -32,906,000 -31,140,000 -28,461,000 -44,622,000 -86,583,000 -39,459,000 -10,826,000 231,899,000 -35,337,000 169,919,000 -6,053,000 -63,000 -1,074,000 -8,662,672 
          cash and cash equivalents – beginning of period
        		  7,395,000 6,651,000 84,220,000  2,271,000 -7,993,000 87,520,000  0 0 176,683,000  0 0 313,812,000  0 0 218,781,000  0 0 90,315,000  486 
          cash and cash equivalents – end of period
        		  8,105,000 7,395,000 90,871,000  -58,000 2,271,000 79,527,000  -24,311,000 -22,090,000 149,767,000  -31,140,000 -28,461,000 269,190,000  -39,459,000 -10,826,000 450,680,000  169,919,000 -6,053,000 90,252,000  -8,662,186 
          net loss
        		    -3,914,000 -44,124,000 3,609,000 1,710,000 -19,722,000 -30,646,000 -31,941,000 -36,767,000 -37,531,000 -38,021,000 -40,167,000 -46,716,000 -51,242,000 -46,451,000 -36,343,000 -24,393,000 -10,974,000 -8,096,000 -6,713,000 -6,371,000 -6,112,000 -3,668,000 -2,437,200 
          adjustments to reconcile net loss to net cash from operating activities:
        		                           
          net decrease in cash and cash equivalents
        		     -3,242,000   -7,993,000  -24,311,000 -22,090,000 -26,916,000               
          cash and cash equivalents—end of year
        		                           
          change in fair value of contingent consideration liabilities
        		                 49,000 0         
          proceeds from issuance of common stock in equity offerings, net of underwriters' discounts and commissions
        		                 0 0 0 245,813,000 0      
          non-cash stock-based compensation expense
        		                           
          deferred tax asset
        		             -81,000 75,000 216,000 224,000 -365,000 229,000 154,000 125,000 -344,000 170,000 53,000 56,000   
          changes in operating assets and liabilities, net of acquisitions:
        		                           
          lease liability
        		             -321,000 -334,000 -341,000 -306,000 -281,000 -235,000 -209,000 -335,000 -367,000 -664,000 -253,000 -502,000   
          payment of offering costs
        		                     -64,000    -273,000 -2,013,569 
          insurance financing agreement
        		                           
          debt issuance costs and facility fees
        		                           
          payments of revolving line of credit
        		                         0 -444 
          payment of contingent consideration for acquisitions
        		                  0         
          change in fair value of warrants liability
        		                         0 41 
          payment of preferred stock dividends
        		                         0 101 
          debt issuance costs
        		                     0 0   0 4 
          loan facility fee payment
        		                 0 0   0 0 -125,000 -100,000   
          proceeds from revolving line of credit
        		                         0 444 
          proceeds from term loan
        		                         0 0 
          repayment of term loan and loan payable
        		                           
          purchase of property and equipment
        		                  -11,566,000 -1,047,000 -3,983,000  -1,781,000 -2,742,000 -1,917,000  -2,071,522 
          amortization of debt discount
        		                    72,000 71,000 73,000 119,000 126,000 33,000 146,686 
          deferred contract acquisition cost amortization
        		                    575,000       
          payments of offering costs
        		                    -30,000       
          principal payments on financing arrangements
        		                    -673,000 -810,000 -661,000     
          cash flows from operating activities:
        		                           
          stock compensation expense
        		                           
          cash flows from investing activities:
        		                           
          cash flows from financing activities:
        		                           
          tax withholdings on stock compensation awards
        		                           
          insurance financing arrangement
        		                     0 0     
          principal portion of finance lease payments
        		                     -833,000 -496,000     
          cash from operating activities:
        		                           
          cost of hardware purchased by customers
        		                      165,000     
          changes in operating assets and liabilities
        		                           
          cash from investing activities:
        		                           
          cash from financing activities:
        		                           
          treasury stock to recover tax withholdings on stock compensation awards
        		                           
          right-of-use assets recorded in exchange for operating lease liabilities
        		                      1,237,000     
          purchase of property and equipment and capitalized software included in accounts payable
        		                      323,000     
          issuance of warrants related to debt
        		                         0  
          cashless transfer of term loan and related accrued fees into increase in debt balance
        		                      0     
          cashless transfer of lender fees through increase in debt balance
        		                      0     
          deferred offering costs included in accounts payable and accrued liabilities
        		                           
          cashless exercise of common stock warrants
        		                          602,218 
          cash payments for:
        		                           
          includes 2,741 initial right of use asset recorded upon adoption of asc 842.
        		                           
          proceeds from ipo, net of underwriters' discounts and commissions
        		                           
          repayment of term loan
        		                         0 -333 
          repayment of loan payable
        		                         0 0 
          purchase of treasury stock
        		                           
          deferred issuance costs included in accounts payable and accrued expenses
        		                           
          accrued expenses
        		                         583,000 -231,991 
          acquisition
        		                           
          proceeds from ipo
        		                         0  
          proceeds from loan payable
        		                           
          payments of capital leases
        		                           
          proceeds from issuance of preferred stock
        		                           
          disclosures of additional investing and financing activities:
        		                           
          supplemental information:
        		                           
          property and equipment acquisitions through capital leases
        		                         309,000 228,055 
          deferred debt issuance costs included in accrued expenses
        		                           
          shares issued in connection with acquisition
        		                           
          net exercise of preferred stock warrant
        		                           
          payment on capital leases
        		                          -459,900 
          purchase of property and equipment included in accounts payable
        		                          -152,579 
          proceeds from ipo, net of underwriters’ discounts and commissions
        		                           
          issurance of warrants related to debt